Predictors of Long-Term Survival in Patients with Idiopathic Pulmonary Fibrosis: Data from the IPF-PRO Registry
Among patients enrolled in the IPF-PRO Registry, a decision tree that included DLco % predicted, oxygen use and FVC % predicted facilitated the prediction of survival > 5 years. Understanding predictors of longer-term survival may facilitate conversations with patients about their prognosis and treatment.
Authors
- Jeremy M. Weber (ORCID: https://orcid.org/0000-0002-7221-8821)
- Paul Sachs
- Justin M. Oldham (ORCID: https://orcid.org/0000-0003-4957-8869)
- A. Jbeli (ORCID: https://orcid.org/0000-0001-6804-4737)
- Mary K. Porteous
- John A. Belperio (ORCID: https://orcid.org/0000-0003-2379-5486)
- Tessy Paul (ORCID: https://orcid.org/0009-0005-1393-7729)
- M. Kokoszynska (ORCID: https://orcid.org/0000-0001-9418-9315)
- Amy L. Olson (ORCID: https://orcid.org/0000-0002-5368-0412)
- Lisa Lancaster (ORCID: https://orcid.org/0000-0001-8465-7357)
- Megan L. Neely (ORCID: https://orcid.org/0000-0002-0101-1081)
- Peide Li (ORCID: https://orcid.org/0000-0002-5110-6150)
- Amy Hajari Case (ORCID: https://orcid.org/0000-0001-8663-2022)
- Shirin Shafazand
- Rajat Walia (ORCID: https://orcid.org/0000-0001-5036-2921)
- Lake Morrison (ORCID: https://orcid.org/0000-0002-5658-0927)
- Hiram Rivas-Perez
- Tristan J. Huie (ORCID: https://orcid.org/0000-0003-0390-1253)
- Tracy Luckhardt (ORCID: https://orcid.org/0000-0002-4063-5989)
- Andrew M. Namen (ORCID: https://orcid.org/0000-0001-5003-0900)
- Robert J. Kaner (ORCID: https://orcid.org/0000-0003-0527-576X)
- Nishant Gupta (ORCID: https://orcid.org/0000-0001-9112-1315)
- Randolph J. Lipchik (ORCID: https://orcid.org/0000-0002-7071-9198)
- Rany Condos
- Albert Baker
- Hyun Joo Kim (ORCID: https://orcid.org/0000-0001-7986-7798)
- Tonya Russell
- Mary E. Strek (ORCID: https://orcid.org/0000-0002-7671-1023)
- Kevin Flaherty (ORCID: https://orcid.org/0000-0003-2657-1314)
- Yolanda Mageto (ORCID: https://orcid.org/0000-0003-4401-8758)
- Francis Cordova (ORCID: https://orcid.org/0009-0004-7468-7121)
- Daniel F. Dilling (ORCID: https://orcid.org/0000-0002-9723-510X)
- Laurie D. Snyder (ORCID: https://orcid.org/0000-0002-5962-2184)
- Zeenat Safdar (ORCID: https://orcid.org/0000-0002-8984-8205)
- Murali Ramaswamy
- Brian D. Southern (ORCID: https://orcid.org/0000-0003-2983-5741)
- Timothy Liesching (ORCID: https://orcid.org/0000-0002-7163-2596)
- Jason Lobo
- Joseph A. Lasky (ORCID: https://orcid.org/0000-0002-8945-4863)
- Mridu Gulati (ORCID: https://orcid.org/0000-0002-4082-1351)
- Doug Lee (ORCID: https://orcid.org/0000-0002-8018-4043)
- David Zhang (ORCID: https://orcid.org/0000-0002-2983-9796)
- John Fitzgerald
- Rishi Raj
- Timothy P. Whelan
- Ather Siddiqi (ORCID: https://orcid.org/0000-0001-5019-2467)
- Kalpalatha K. Guntupalli
- Scott Beegle
- Ray Fowler
- David Hotchkin (ORCID: https://orcid.org/0009-0008-7006-2158)
- Jeremy Tabak
- Kevin J. Gibson
Institutions
- University of Minnesota (US)
- Clinical Research Institute (US)
- Duke Medical Center (US)
- Piedmont HealthCare (US)
- Boehringer Ingelheim (United States) (US)
Publication Details
- Journal
- Lung
- Published
- 2025-03-09
- DOI
- https://doi.org/10.1007/s00408-025-00797-4
- Citations
- 3
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 4.56
Funders
- Duke Clinical Research Institute